A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants
Status:
Completed
Trial end date:
2020-09-13
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the PK of AMG 510 alone and in combination
with either famotidine or omeprazole in healthy participants under fed conditions.